19 November 2011

KEC International - 2QFY2012 Result Update : Angel Broking

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


KEC International’s (KEC) 2QFY2012 results exceeded ours and street’s
expectations on the top-line front, but the company’s performance was very
disappointing on the bottom-line front. Order inflow for the quarter totaled
`1,200cr and order backlog stood at `8,450cr. We have lowered our earnings
estimates by 30.0%/26.7% for FY2012E/FY2013E, respectively, to factor in the
margin contraction and changed business environment. We downgrade the
stock’s rating to Neutral.
Strong execution continues; margin contraction a surprise: Consolidated revenue
grew by 26.2% yoy to `1,263cr (`1,001cr), higher than ours and street’s
estimates. On the EBITDAM front, KEC witnessed a steep contraction to 7.2%
mainly due to high raw-material prices, problems in regions such as Egypt and
Libya, and execution of low-margin orders. Further, higher interest cost and tax
incidence dragged down KEC’s earnings (adjusted), leading to a 55.2% yoy dip to
`21.7cr.
Outlook and valuation: The overall slowdown in the power sector has left
transmission EPC companies to reel under pressure. In addition, competition has
intensified on the domestic front, thereby leading to pricing pressures. This is the
first time KEC has witnessed a sharp margin contraction, which we believe is here
to stay in the coming quarters as well, given its reflection of stress in the business
environment, and thereby putting pressure on earnings growth. Further, lack of
positive news flows (read sector related) would keep the stock rise under check.
Notably, KEC’s stock has fallen by ~28% and underperformed the BSE Sensex by
~24% over the last three months. At the CMP of `57, the stock trades 8.4x and
6.2x, FY2012E and FY2013E, EPS, respectively. Despite attractive valuations,
we downgrade the stock’s rating to Neutral with a fair value of `56.

No comments:

Post a Comment